1. Home
  2. UTSI vs TXMD Comparison

UTSI vs TXMD Comparison

Compare UTSI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

HOLD

Current Price

$2.43

Market Cap

23.7M

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

N/A

Current Price

$2.30

Market Cap

25.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTSI
TXMD
Founded
1991
2008
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
25.9M
IPO Year
1999
2012

Fundamental Metrics

Financial Performance
Metric
UTSI
TXMD
Price
$2.43
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1K
27.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.61
EPS
N/A
N/A
Revenue
N/A
$1,761,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.64
Revenue Growth
N/A
35.25
52 Week Low
$1.94
$0.72
52 Week High
$2.94
$2.95

Technical Indicators

Market Signals
Indicator
UTSI
TXMD
Relative Strength Index (RSI) 49.51 54.29
Support Level $2.38 $1.05
Resistance Level $2.55 $2.54
Average True Range (ATR) 0.05 0.12
MACD -0.00 -0.01
Stochastic Oscillator 55.88 74.24

Price Performance

Historical Comparison
UTSI
TXMD

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: